Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Ionescu, Filip, Ajayi, Eloho, Leach, Aamia, Alsina, Melissa, Bejanyan, Nelli, Castaneda-Puglianini, Omar, Elmariah, Hany, Freeman, Ciara L., Hansen, Doris K., Jain, Michael D., Khimani, Farhad, Lazaryan, Aleksandr, Liu, Hien D., Locke, Frederick L., McIver, Bryan, Mishra, Asmita, Nieder, Michael, Ochoa, Jose, Perez, Lia, Pidala, Joseph, Baluch, Aliyah, Klinkova, Olga, Quilitz, Rod, Nishihori, Taiga, Faramand, Rawan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665246/
http://dx.doi.org/10.1182/blood-2022-170337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665246/
http://dx.doi.org/10.1182/blood-2022-170337

Ejemplares similares